Fundraising FoxCellTrack
Madison, US · Founded 2026 · Delaware corporation · 1 known investors
Find your way into CellTrack
Sign up to see every warm intro you have to CellTrack
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CellTrack team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CellTrack develops a cell-labeling technology that attaches Zirconium-89 to therapeutic cells for non-invasive PET imaging, allowing tracking of cell biodistribution in vivo for over 7 days. The company targets pharma companies and CDMOs developing cell therapies, aiming to provide biodistribution data for clinical trials.
Founders & leadership
VS
Victor Santoro FernandesFounder & CEOHe completed his PhD in the Medical Physics Department at the University of Wisconsin-Madison, where he now holds an Entrepreneurial Fellowship and previously served as an ambassador for the Wisconsin Alumni Research Foundation. Before that, he earned a master's degree at the Universidade de São Paulo and worked as a data scientist at Semantix.
RH
Reinier HernandezFounder & Chief Scientific AdvisorHe is an Assistant Professor of Medical Physics and Radiology at the University of Wisconsin-Madison, where he trained as an NSF GRFP fellow and NIH trainee before continuing as a research associate. He also serves as Chief Technology Officer at Archeus Technologies, co-founded RPT Labworks, and previously worked as a scientist at Teva Pharmaceuticals and a research intern at Radboudumc.
Board
RD
Robert DrapeBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$30K disclosed across 1 round · 2026
▶$30KraisedJul 2026 · 1 investors · BiotechnologyRule 506(b)
▶$30KraisedJul 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Victor Santoro FernandesExecutive Officer, Director
- Reinier HernandezDirector
- Robert DrapeDirector
- Offering amount
- $600K
- Amount sold
- $30K
- Minimum investment
- $5K
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does CellTrack do?
- CellTrack develops a cell-labeling technology that attaches Zirconium-89 to therapeutic cells for non-invasive PET imaging, allowing tracking of cell biodistribution in vivo for over 7 days. The company targets pharma companies and CDMOs developing cell therapies, aiming to provide biodistribution data for clinical trials.
- Who are CellTrack's investors?
- CellTrack's investors include Gener8tor.
- How much funding has CellTrack raised?
- CellTrack has disclosed $30K raised across 1 round.
- Where is CellTrack headquartered?
- CellTrack is headquartered in Madison, US.